Skip to content

Impact of speech therapy on dysphagia and trismus in head-and-neck cancer patients

Impact of speech therapy on dysphagia and trismus in head-and-neck cancer patients - SPODHAP

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00021287
Enrollment
66
Registered
2020-05-18
Start date
2020-07-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C10 C13

Interventions

Group 1: Patients in the intervention group receive speech therapy by a speech therapist biweekly for 30 minutes per therapy session. Standard exercises for dysphagia and trismus are applied, whereby

Sponsors

Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patients with a histologically proven, locally advanced (=T3 and/or N+) carcinoma of the oro- or hypopharynx without distant metastases; • Indication for a definitive or adjuvant (chemo)radiotherapy with an intended radiation dose between 50 Gy and 70 Gy; • Age = 18 years; • Karnofsky performance status = 70%; • Patient education and written consent for participation in the study

Exclusion criteria

Exclusion criteria: • Considerable neurological or psychiatric diseases including dementia and epilepsy; • Medical condition that impairs successful completion of the study or impedes adequate patient education; • Previous tumor treatment (surgery or irradiation) in the head-and-neck region > 3 months ago; • Impairment of the swallowing function prior to radiotherapy treatment, e.g. after other operative interventions in the head-and-neck region; • Lack of legal capacity

Design outcomes

Primary

MeasureTime frame
Bogenhausener Dysphagia Score (BODS) at 3 months after radiotherapy.

Secondary

MeasureTime frame
BODS at 6 and 24 months after radiotherapy; Quality of life quantified by EQ-5D-5L, DHI and EORTC H&N 35 questionnaires; Body weight; Maximum mouth opening; Prevalence of percutaneous endoscopic gastrostomy (PEG).

Countries

Germany

Contacts

Public ContactAlexander Rühle

Universitätsklinikum Freiburg, Department für Radiologische Diagnostik und Therapie, Klinik für Strahlenheilkunde

alexander.ruehle@uniklinik-freiburg.de0761 270-95151

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026